UROKINASE PLASMINOGEN-ACTIVATOR, A STRONG AND INDEPENDENT PROGNOSTIC MARKER IN BREAST-CANCER

被引：0
|
作者：
DUFFY, MJ
REILLY, D
NOLAN, N
OHIGGINS, N
FENNELLY, JJ
ANDREASEN, P
机构：
[1] ST VINCENTS HOSP,DEPT EDUC,DUBLIN 4,IRELAND
[2] ST VINCENTS HOSP,DEPT RES,DUBLIN 4,IRELAND
[3] AARHUS UNIV,INST MOLEC BIOL,DK-8000 AARHUS,DENMARK
来源：
FIBRINOLYSIS | 1992年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Urokinase plasminogen activator (uPA) is a serine protease implicated in cancer invasion and metastasis. In this investigation, we show using both univariate and multivariate analysis that high levels of uPA antigen in primary breast cancer correlates with shortened disease-free interval and shortened overall survival. As a prognostic marker for breast cancer, uPA appears to be stronger than either axillary node status, tumor size, or estrogen receptor (ER) status. In addition, as a prognostic marker, uPA was independent of nodal status, tumor size and ER status. We conclude that uPA is a new and independent prognostic marker in breast cancer.
引用
收藏
页码：55 / 57
页数：3
相关论文
共 50 条
  • [31] DIFFERENTIAL BIOLOGICAL SIGNIFICANCE OF TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN BREAST-CANCER
    YAMASHITA, J
    OGAWA, M
    YAMASHITA, S
    NAKASHIMA, Y
    SAISHOJI, T
    NOMURA, K
    INADA, K
    KAWANO, I
    BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 524 - 529
  • [32] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) ANTIGEN IS A PREDICTOR OF EARLY RELAPSE IN BREAST-CANCER
    JANICKE, F
    SCHMITT, M
    HAFTER, R
    HOLLRIEDER, A
    BABIC, R
    ULM, K
    GOSSNER, W
    GRAEFF, H
    FIBRINOLYSIS, 1990, 4 (02) : 69 - 78
  • [33] THE UROKINASE TYPE OF PLASMINOGEN-ACTIVATOR IN CANCER OF DIGESTIVE TRACTS
    NISHINO, N
    AOKI, K
    TOKURA, Y
    SAKAGUCHI, S
    TAKADA, Y
    TAKADA, A
    THROMBOSIS RESEARCH, 1988, 50 (04) : 527 - 535
  • [34] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AS MARKER OF FUNCTIONAL STEROID-RECEPTORS IN HUMAN BREAST-CANCER
    RELLA, C
    COVIELLO, M
    QUARANTA, M
    PARADISO, A
    THROMBOSIS RESEARCH, 1993, 69 (02) : 209 - 220
  • [35] PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND PROGNOSIS IN PRIMARY BREAST-CANCER
    FOEKENS, JA
    SCHMITT, M
    VANPUTTEN, WLJ
    PETERS, HA
    KRAMER, MD
    JANICKE, F
    KLIJN, JGM
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) : 1648 - 1658
  • [36] PLASMINOGEN-ACTIVATOR ACTIVITY AND STEROID-RECEPTORS IN PRIMARY BREAST-CANCER
    THORSEN, T
    ACTA ENDOCRINOLOGICA, 1981, 97 : 268 - 268
  • [37] IMMUNOHISTOCHEMICAL LOCALIZATION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN BREAST-CANCER
    BIANCHI, E
    COHEN, RL
    DAI, A
    THOR, AT
    SHUMAN, MA
    SMITH, HS
    INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (05) : 597 - 603
  • [38] PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS
    BOUCHET, C
    SPYRATOS, F
    MARTIN, PM
    HACENE, K
    GENTILE, A
    OGLOBINE, J
    BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 398 - 405
  • [39] Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease
    Duffy, MJ
    Duggan, C
    Mulcahy, HE
    McDermott, EW
    O'Higgins, NJ
    CLINICAL CHEMISTRY, 1998, 44 (06) : 1177 - 1183
  • [40] UROKINASE-PLASMINOGEN ACTIVATOR IN BREAST-CANCER - ASSAY BY BOTH CATALYTIC AND IMMUNOASSAY
    REILLY, D
    ANDREASEN, PA
    DUFFY, MJ
    BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (01) : 47 - 50
12345